EPO and depressive disorder: Anxiety, depression, somatoform, and phobic disorders are frequently seen comorbidities.15,16 The present study demonstrates, for the first time in the literature, that the prevalence of IBS in HD or PD patients is high and related to the presence of CAD and EPO use.